Search research articles
Contact Us
Filters
Showing results (21-30 of 37) with videos related to
Page
of 4
Sort By:
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 11, 2012
Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomy
Ranjit Manchanda, Anna Silvanto, Ahmed Abdelraheim, et al.
Ebiomedicine
|
December 3, 2015
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
Martin Widschwendter, Matthew Burnell, Lindsay Fraser, et al.
The Lancet. Oncology
|
October 22, 2013
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
Martin Widschwendter, Adam N Rosenthal, Sue Philpott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2012
Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule
Adam N Rosenthal, Lindsay Fraser, Ranjit Manchanda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 12, 2026
Transforming endometrial cancer diagnosis: the case for molecular triage in abnormal uterine and post-menopausal bleeding
Adeola Olaitan, Nora Pashayan, John Butler, et al.
JAMA Network Open
|
February 9, 2024
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer
Xia Wei, Li Sun, Eric Slade, et al.
Cancers
|
March 28, 2024
Natural Killer Cell Dysfunction in Premenopausal <i>BRCA1</i> Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis
Shaun Haran, Kantaraja Chindera, May Sabry, et al.
International Journal of Cancer
|
October 20, 2023
Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial
Chiara Herzog, Allison Jones, Iona Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.
Gynecologic Oncology
|
June 19, 2015
A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass
Mona A Karlsen, Estrid V S Høgdall, Ib J Christensen, et al.
Page
of 4
Search research articles
Search
Showing results (21-30 of 37) with videos related to
Sort By:
Page
of 4
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
May 11, 2012
Diathermy-induced injury may affect detection of occult tubal lesions at risk-reducing salpingo-oophorectomy
Ranjit Manchanda, Anna Silvanto, Ahmed Abdelraheim, et al.
Ebiomedicine
|
December 3, 2015
Osteoprotegerin (OPG), The Endogenous Inhibitor of Receptor Activator of NF-κB Ligand (RANKL), is Dysregulated in BRCA Mutation Carriers
Martin Widschwendter, Matthew Burnell, Lindsay Fraser, et al.
The Lancet. Oncology
|
October 22, 2013
The sex hormone system in carriers of BRCA1/2 mutations: a case-control study
Martin Widschwendter, Adam N Rosenthal, Sue Philpott, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
December 6, 2012
Results of annual screening in phase I of the United Kingdom familial ovarian cancer screening study highlight the need for strict adherence to screening schedule
Adam N Rosenthal, Lindsay Fraser, Ranjit Manchanda, et al.
International Journal of Gynecological Cancer : Official Journal of the International Gynecological Cancer Society
|
June 12, 2026
Transforming endometrial cancer diagnosis: the case for molecular triage in abnormal uterine and post-menopausal bleeding
Adeola Olaitan, Nora Pashayan, John Butler, et al.
JAMA Network Open
|
February 9, 2024
Cost-Effectiveness of Gene-Specific Prevention Strategies for Ovarian and Breast Cancer
Xia Wei, Li Sun, Eric Slade, et al.
Cancers
|
March 28, 2024
Natural Killer Cell Dysfunction in Premenopausal <i>BRCA1</i> Mutation Carriers: A Potential Mechanism for Ovarian Carcinogenesis
Shaun Haran, Kantaraja Chindera, May Sabry, et al.
International Journal of Cancer
|
October 20, 2023
Plasma cell-free DNA methylation analysis for ovarian cancer detection: Analysis of samples from a case-control study and an ovarian cancer screening trial
Chiara Herzog, Allison Jones, Iona Evans, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
February 28, 2017
Evidence of Stage Shift in Women Diagnosed With Ovarian Cancer During Phase II of the United Kingdom Familial Ovarian Cancer Screening Study
Adam N Rosenthal, Lindsay S M Fraser, Susan Philpott, et al.
Gynecologic Oncology
|
June 19, 2015
A novel diagnostic index combining HE4, CA125 and age may improve triage of women with suspected ovarian cancer - An international multicenter study in women with an ovarian mass
Mona A Karlsen, Estrid V S Høgdall, Ib J Christensen, et al.
Page
of 4